£670K
The financing round was backed by Infinion Biopharma, the Scottish Investment Bank, Scottish Health Innovations, and TRICAPITAL.
AB
Aurum Biosciences
Aurum Biosciences develops novel oxygen carriers and diagnostic software for clinical use.
£670KTotal raised
Aurum Biosciences is a clinical stage biopharmaceutical company developing novel oxygen carriers and diagnostic software for MRI applications. The firm focuses on addressing serious medical conditions including stroke, cardiology, oncology, and neuro-degenerative diseases.
Categories
Team
JM
Jim McGuire
CEO
Jim brings executive experience from leadership roles at Aurum Biosciences and Clear Surgical, alongside consultancy work.
LinkedIn